ALX Oncology
Edit

ALX Oncology

http://alxoncology.com/
Last activity: 07.03.2024
Categories: BioTechDevelopmentDrugHumanProduct
ALX Oncology is a clinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Followers
240
Mentions
9
Location: United States, California, South San Francisco
Employees: 11-50
Total raised: $105M
Founded date: 2015

Investors 6

Funding Rounds 1

DateSeriesAmountInvestors
12.02.2020Series C$105M-

Mentions in press and media 9

DateTitleDescriptionSource
07.03.2024ALX Oncology Reports Fourth Quarter and Full Year 2023 Finan...-globenewsw...
05.03.2024ALX Oncology Announces Two Evorpacept Clinical Abstracts Acc...-globenewsw...
03.10.2023When is a Wall Street disappointment ‘good enough’ for the F...Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne...statnews.c...
01.11.2022Bet­ting on CD47 as oth­ers ditch the tar­get, ALX bor­rows ...At its peak, ALX On­col­o­gy $ALXO was trad­ing at $88 per share, rid­ing on the promise of block­in...endpts.com...
12.02.2020ALX raises $105M for midphase trials of CD47 cancer drugALX Oncology has raised $105 million. The series C round will support phase 2 trials of CD47 myeloid...fiercebiot...
12.02.2020ALX raises $105M for midphase trials of CD47 cancer drugALX Oncology has raised $105 million. The series C round will support phase 2 trials of CD47 myeloid...fiercebiot...
12.02.2020ALX Oncology Announces Closing of $105 Million Series C Fina...-lightstone...
12.02.2020ALX Oncology raises $105M in Series C round for checkpoint i...The company plans to invest the money in its lead drug candidate, ALX148, a CD47-targeting checkpoin...medcitynew...
-ALX Oncology raises $105M in Series C round for checkpoint i...A company developing a drug that targets a protein overexpressed on the surface of cancer cells and ...medcitynew...

Reviews 0

Sign up to leave a review

Sign up Log In